Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1274 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
CELIVARONE
Not marketed
Atrial Fibrillation
DRI5165MAIANCT00233441Publication's reference
CELIVARONE
Not marketed
Arrhythmia
DRI5349ICARIOSNCT00232297Publication's reference
CELIVARONE
Not marketed
Atrial Fibrillation
DRI5760CORYFEENCT00232310Publication's reference
CETYLPYRIDINIUM CHLORIDE
Cepacol Canela Power
Hygiene
CPYRY_L_03930NANCT00687037Summary
CETYLPYRIDINIUM CHLORIDE
Cepacol Canela Power
Hygiene
CPYRY_L_04020NANCT00729599Summary
CICLESONIDE
Alvesco
Asthma
DFI6153 (AVE2635A/2001)NANCT00174746Summary
CICLESONIDE
Alvesco
Asthma
EFC6161 (XRP1526B/3028)NASummary
CICLESONIDE
Alvesco
Asthma
EFC6163 (XRP1526B/3030)NANCT00174733Summary
CICLESONIDE
Alvesco
Asthma
EFC6164 (XRP1526B/3031)NANCT00174720Summary
CICLESONIDE
Alvesco
Asthma
SFY6160 (XRP1526B/3027)NANCT00254956Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted